MMP9: A Tough Target for Targeted Therapy for Cancer.

Area of Science:

• Oncology
• Biochemistry
• Molecular Biology

Background:

• Matrix metalloproteinase 9 (MMP9) is a secretory endopeptidase involved in diverse biological processes.
• MMP9 plays a critical role in tumorigenesis, including extracellular matrix remodeling, cell migration, and angiogenesis.
• Its involvement in cancer-related inflammation and tumor microenvironment formation is increasingly recognized.

Purpose of the Study:

• To review the current understanding of MMP9's role in cancer growth.
• To explore MMP9's involvement in cell adhesion, migration, inflammation, and tumor microenvironment.
• To summarize the progress and challenges in developing selective MMP9 inhibitors for cancer therapy.

Main Methods:

• Literature review of scientific publications on MMP9 and cancer.
• Analysis of MMP9's functions in key cancer processes.
• Evaluation of current MMP9 inhibitor development and clinical applications.

Main Results:

• MMP9 significantly contributes to cancer progression through matrix degradation and promotion of invasion and metastasis.
• MMP9 influences cancer-associated inflammation and shapes the tumor microenvironment, impacting treatment response.
• Selective MMP9 inhibitors have been developed, but their efficacy and limitations as standalone anticancer agents require further investigation.

Conclusions:

• MMP9 is a key target in cancer research due to its multifaceted roles in tumor progression.
• Targeting MMP9 offers potential therapeutic strategies, but overcoming resistance and side effects is crucial.
• Further research is needed to optimize MMP9-targeted therapies for effective cancer treatment.